{"id":"W4399881049","doi":"10.1200/jco.2024.42.16_suppl.4111","title":"Atezolizumab + bevacizumab versus lenvatinib as first-line systemic therapy for treatment of hepatocellular carcinoma in a real-world population: Outcomes from the HCC CHORD database.","year":2024,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Hepatocellular Carcinoma Treatment and Prognosis","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"ca_institutions":"CancerCare Manitoba; McMaster University; Juravinski Cancer Centre; BC Cancer Agency; University of Manitoba; Princess Margaret Cancer Centre; Dalhousie University; University of Toronto; University Health Network; University of British Columbia; University of Calgary","funders":"","keywords":"Lenvatinib; Medicine; Atezolizumab; Hepatocellular carcinoma; Bevacizumab; Oncology; Systemic therapy; Hepatocellular cancer; Internal medicine; Population; Regorafenib; Cancer; Colorectal cancer; Sorafenib; Chemotherapy; Pembrolizumab","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":true,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001329664,0.0003098657,0.000818637,0.0006532939,0.00034283,0.0008510359,0.0006594792,0.0005330853,0.00166367],"category_scores_gemma":[0.003106597,0.0001820831,0.001065662,0.001579863,0.0003086619,0.000432508,0.0006316518,0.0005658061,0.0002864835],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.002537807,"about_ca_system_score_gemma":0.002551443,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0472706,"about_ca_topic_score_gemma":0.08692731,"domain_scores_codex":[0.9990575,0.0003298413,0.0001172334,0.0001667381,0.0001990196,0.0001297129],"domain_scores_gemma":[0.9973628,0.000580196,0.001174438,0.0001508269,0.0002806209,0.0004511498],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.04827213,0.0008309144,0.9210245,0.0009943402,0.003539936,0.0003475714,0.0002425208,0.000962152,0.0004834224,0.0001171995,0.005827516,0.01735784],"study_design_scores_gemma":[0.00988315,0.00415853,0.9729816,0.000252881,0.003473125,0.001009064,0.0007732552,0.002568696,0.0002939304,0.0001249221,0.004426186,0.00005453134],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9857848,0.002141569,0.00008659266,0.0002494743,0.00001627517,0.000154906,0.01081597,0.000008520745,0.0007419855],"genre_scores_gemma":[0.9816728,0.00109572,0.0001941026,0.0002456306,0.00004348624,0.0001218686,0.01635207,0.000004604907,0.0002695858],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.0472706,"threshold_uncertainty_score":0.09399092,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.3439999818481217,"score_gpt":0.456259977843159,"score_spread":0.1122599959950373,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}